Sequence information
Variant position: 267 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 393 The length of the canonical sequence.
Location on the sequence:
NRRPILTIITLEDSSGNLLG
R NSFEVRVCACPGRDRRTEEE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human NRRPILTIITLEDSSGNLLGR NSFEVRVCACPGRDRRTEEE
NRRPILTIITLEDSSGNVLGR NSFEVRVCACPGRDRRTEEE
Rhesus macaque NRRPILTIITLEDSSGNLLGR NSFEVRVCACPGRDRRTEEE
Mouse NRRPILTIITLEDSSGNLLGR DSFEVRVCACPGRDRRTEEE
Rat NRRPILTIITLEDSSGNLLGR DSFEVRVCACPGRDRRTEEE
Pig NRRPILTIITLEDASGNLLGR NSFEVRVCACPGRDRRTEEE
Bovine NRRPILTIITLEDSCGNLLGR NSFEVRVCACPGRDRRTEEE
Rabbit NRRPILTIITLEDSSGNLLGR NSFEVRVCACPGRDRRTEEE
Sheep NRRPILTIITLEDSRGNLLGR SSFEVRVCACPGRDRRTEEE
Cat NRRPIITIITLEDSNGKLLGR NSFEVRVCACPGRDRRTEEE
Chicken NRRPILTILTLEGPGGQLLGR RCFEVRVCACPGRDRKIEEE
Xenopus laevis NRRPILTIITLETPQGLLLGR RCFEVRVCACPGRDRRTEED
Zebrafish NRRPILTIITLETQEGQLLGR RSFEVRVCACPGRDRKTEES
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 393
Cellular tumor antigen p53
DNA binding
102 – 292
Region
1 – 320
Interaction with CCAR2
Region
100 – 370
Interaction with HIPK1
Region
100 – 300
Required for interaction with ZNF385A
Region
116 – 292
Interaction with AXIN1
Region
256 – 294
Interaction with E4F1
Modified residue
269 – 269
Phosphoserine; by AURKB
Modified residue
284 – 284
Phosphothreonine; by AURKB
Mutagenesis
248 – 248
R -> S. Does not induce SNAI1 degradation.
Mutagenesis
269 – 269
S -> A. Abolishes phosphorylation.
Mutagenesis
269 – 269
S -> E. Inhibits strongly its transcriptional activity.
Mutagenesis
284 – 284
T -> E. Inhibits strongly its transcriptional activity.
Beta strand
264 – 274
Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.